# EDGAR Filing Document

**Accession Number:** 0000320121
**File Stem:** 0000320121-26-000008
**Filing Date:** 2026-3
**Character Count:** 53670
**Document Hash:** 4648c42e229eb74f5666a27d5a4105a1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000320121-26-000008.hdr.sgml**: 20260316

**ACCESSION NUMBER**: 0000320121-26-000008

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20260316

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260316

**DATE AS OF CHANGE**: 20260316

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TELOS CORP
- **CENTRAL INDEX KEY:** 0000320121
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 520880974
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-08443
- **FILM NUMBER:** 26754689

**BUSINESS ADDRESS:**
- **STREET 1:** 19886 ASHBURN ROAD
- **CITY:** ASHBURN
- **STATE:** VA
- **ZIP:** 20147
- **BUSINESS PHONE:** 7034716000

**MAIL ADDRESS:**
- **STREET 1:** 19886 ASHBURN ROAD
- **CITY:** ASHBURN
- **STATE:** VA
- **ZIP:** 20147

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** C3 INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? tls-20260316

.

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**March 16, 2026**

Date of Report (Date of earliest event reported)

**TELOS CORPORATION**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Maryland** | **001-08443** | **52-0880974** |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |

---

---

| | |
|:---|:---|
| **19886 Ashburn Road,** | |
| **Ashburn, Virginia** | **20147-2358** |
| (Address of principal executive offices) | (Zip Code) |

---

---

| |
|:---|
| **(703) 724-3800** |
| (Registrant's telephone number, including area code) |

---

**NOT APPLICABLE**

(Former name, former address, and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading symbol | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name of each exchange on which registered |
| **Common stock, $0.001 par value per share** | **TLS** | **The Nasdaq Stock Market LLC** |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

.

------

.

**Item 2.02.&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.** 

On Monday, March 16, 2026, Telos Corporation (the "Company") issued a press release announcing a conference call to discuss its financial results for the fourth quarter and year ended December 31, 2025, and posted those financial results on its website. A copy of the press release and financial results for the fourth quarter and year ended December 31, 2025 are attached as Exhibit 99.1 and Exhibit 99.2 to this Current Report on Form 8-K and incorporated herein by reference.

The Company will conduct a conference call to discuss its financial results on Monday, March 16, 2026, at 9:30 a.m., Eastern Time. A live broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company's website (<u>https://investors.telos.com</u>).

The information in this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2 attached hereto, is furnished pursuant to Item 2.02 of this Current Report on Form 8-K. Such information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

**Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
| <u>[99.1](q42025earningspressrelease.htm)</u> | <u>[Press Release, issued](q42025earningspressrelease.htm)[March 16, 2026](q42025earningspressrelease.htm)</u> |
| <u>[99.2](q42025december312025financ.htm)</u> | <u>[Fourth Quarter and Year Ended December 31, 2025 Financial Results](q42025december312025financ.htm)</u> |
| 104 | Inline XBRL for the cover page of this Current Report on Form 8-K. |

---

.

------

.

**S I G N A T U R E S**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **TELOS CORPORATION** | **TELOS CORPORATION** |
| By: | /s/ Mark Bendza |
|  | Mark Bendza |
|  | Chief Financial Officer |

---

Date: March 16, 2026

.

## Exhibit 99.1

**Exhibit 99.1**

![image_telos.jpg](image_telos.jpg)

**Telos Corporation Announces Fourth Quarter and Full Year 2025 Earnings**

**Ashburn, Va. – March 16, 2026** – Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world's most security-conscious organizations, has posted its 2025 fourth quarter and full year financial results on its investor relations website at https://investors.telos.com.

Telos will host a live webcast to discuss its fourth quarter and full year 2025 financial results today, March 16, 2026, at 9:30 a.m. ET. To access the webcast, visit https://edge.media-server.com/mmc/p/p99edfa3/.

Related presentation materials will be available in the Investors section of the Company's website. In addition, an archived webcast will be posted on the website approximately two hours after the live event concludes.

**About Telos Corporation**

Telos Corporation (NASDAQ: TLS) empowers and protects the world's most security-conscious organizations with efficient, adaptable, and secure solutions that safeguard people, systems, and information. We deliver advanced capabilities across cyber governance, risk, and compliance (GRC) with Xacta®; identity and biometric solutions; secure networks and communications; and TSA PreCheck® enrollment services. Serving the U.S. federal government, regulated industries, and global enterprises, Telos helps customers stay ahead of evolving threats, accelerate compliance, and achieve mission success. Driven by purpose and guided by our core values, we build trusted partnerships, deliver superior solutions, and help create a more secure, interconnected world. Learn more at www.telos.com.

**Media:** media@telos.com

**Investors:** InvestorRelations@telos.com

## Exhibit 99.2

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Exhibit 99.2**

![image_0a.jpg](image_0a.jpg)

**Fourth Quarter 2025 Financial Results** 

March 16, 2026

Telos Corporation Reports 77% Revenue Growth and Continued Strong Cash Flow Margins in the Fourth Quarter; Forecasts Another Year of Double-Digit Revenue Growth in 2026; Increases Share Repurchase Authorization to $75.0 Million<br>

**• Substantial Growth:** Revenue grew 77% year-over-year to $46.8 million, exceeding guidance, and driven by 105% growth in Security Solutions, primarily due to the ongoing expansion of large programs in Telos ID.

• **Streamlined Cost Structure:** Approved a restructuring plan to further reduce expenses and drive continued operating leverage, resulting in a $1.5 million restructuring charge (including $0.5 million in cost of sales). Recorded a $14.9 million non-cash goodwill impairment in Secure Networks.

**• Healthy Gross Margins:** GAAP Gross Margin was 35.0%; Excluding $0.5 million of restructuring charges in cost of sales, gross margin was 36.0%. Cash Gross Margin<sup>1</sup> was 41.9%, exceeding guidance, primarily due to outperformance within Telos ID.

• **Strong Operating Leverage:** GAAP Net Loss was $16.3 million, inclusive of $1.5 million restructuring charge and $14.9 million non-cash goodwill impairment; Adjusted EBITDA<sup>1</sup> increased $7.5 million year-over-year to $7.3 million, exceeding guidance, primarily due to Revenue and Gross Margin outperformance in Telos ID and lower Adjusted Operating Expenses<sup>1</sup>. Due to significant year-over-year growth in Revenue and Cash Gross Profit<sup>1</sup>, combined with lower Adjusted Operating Expenses<sup>1</sup>, year-over-year Incremental Adjusted EBITDA Margin<sup>1</sup> was 36.7%.

• **Robust Cash Flow Margins:** Cash Flow from Operations was $8.0 million or 17.1% of Revenue and Free Cash Flow<sup>1</sup> improved $21.1 million year-over-year to $6.3 million or 13.4%<sup>1</sup> of Revenue in the fourth quarter. Cash Flow from Operations was $30.2 million or 18.3% of Revenue and Free Cash Flow<sup>1</sup> improved $61.0 million year-over-year to $21.3 million or 12.9%<sup>1</sup> of Revenue for the full year.

• **Continued Share Repurchases:** Deployed $6.0 million to repurchase over one million shares at an average price of $5.78 per share in the fourth quarter. Deployed $13.6 million to repurchase 3.1 million shares at an average price of $4.38 per share for the full year.

• **Financial Guidance:** Forecasting another year of double-digit revenue growth, lower operating expenses, Adjusted EBITDA Margin<sup>2</sup> expansion, and robust cash flow.

---

| | | |
|:---|:---|:---|
| **Financial Guidance for the First Quarter and Full Year Ending December 31, 2026** | **Financial Guidance for the First Quarter and Full Year Ending December 31, 2026** | **Financial Guidance for the First Quarter and Full Year Ending December 31, 2026** |
|  | First Quarter | Full Year |
| Revenue | $44.0 million - $45.0 million | $187 million - $200 million |
| Year-Over-Year Growth | 44% - 47% | 14% - 21% |
| Adjusted EBITDA<sup>2</sup> | $4.5 million - $5.0 million | $20.6 million - $28.0 million |
| Adjusted EBITDA Margin<sup>2</sup> | 10.2% - 11.1% | 11.0% - 14.0% |

---

<sup>1</sup> Cash Gross Margin, Cash Gross Profit, Adjusted Operating Expenses, Adjusted EBITDA, Incremental Adjusted EBITDA Margin, Free Cash Flow and Free Cash Flow Margin are non-GAAP financial measures. Refer to "Non-GAAP Financial Measures" below.

<sup>2</sup>Adjusted EBITDA and Adjusted EBITDA Margin are non-GAAP financial measures. The Company has not provided a reconciliation to the most directly comparable GAAP measure to these forward-looking non-GAAP financial measures because certain items are out of the Company's control or cannot be reasonably predicted. Accordingly, reconciliations of forward-looking Adjusted EBITDA and Adjusted EBITDA Margin are not available without unreasonable effort.

------

---

| | | |
|:---|:---|:---|
| **Fourth Quarter 2025 Financial Highlights** | **Fourth Quarter 2025 Financial Highlights** | **Fourth Quarter 2025 Financial Highlights** |
| | **Three Months Ended** | **Three Months Ended** |
| | **December 31, 2025** | **December 31, 2024** |
|  | *(amounts in millions, except per share data)* | *(amounts in millions, except per share data)* |
| Revenue | $46.8 | $26.4 |
| Gross Profit | $16.4 | $10.6 |
| Gross Margin | 35.0% | 40.3% |
| Adjusted Gross Profit<sup>1</sup> | $17.0 | $10.8 |
| Adjusted Gross Margin<sup>1</sup> | 36.4% | 40.9% |
| Cash Gross Profit<sup>1</sup> | $19.6 | $12.4 |
| Cash Gross Margin<sup>1</sup> | 41.9% | 47.0% |
| GAAP Net Loss | $(16.3) | $(9.3) |
| Adjusted Net Income/(Loss)<sup>1</sup> | $4.5 | $(2.8) |
| EBITDA<sup>1</sup> | $(15.1) | $(7.4) |
| Adjusted EBITDA<sup>1</sup> | $7.3 | $(0.2) |
| Adjusted EBITDA Margin<sup>1</sup> | 15.6% | (0.8%) |
| GAAP EPS | $(0.22) | $(0.13) |
| Weighted-average Shares of Common Stock Outstanding, diluted (GAAP) | 73.1 | 72.4 |
| Adjusted EPS <sup>1</sup> | $0.06 | $(0.04) |
| Weighted-average Shares of Common Stock Outstanding, diluted (non-GAAP)<sup>2</sup> | 78.2 | 72.4 |
| Cash Flow from Operations | $8.0 | $(10.5) |
| Free Cash Flow<sup>1</sup> | $6.3 | $(14.8) |
| Free Cash Flow Margin<sup>1</sup> | 13.4% | (56.1)% |

---

<sup>1</sup> *Adjusted Gross Profit, Adjusted Gross Margin, Cash Gross Profit, Cash Gross Margin, Adjusted Net Income (Loss), EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted EPS, Free Cash Flow, and Free Cash Flow Margin are non-GAAP financial measures. Refer to "Non-GAAP Financial Measures" below.*

<sup>2</sup> *For a period of net loss, potentially dilutive shares are not included in the calculation of diluted earnings (loss) per share, because to do so would be anti-dilutive. This is adjusted to reconcile GAAP earnings (loss) per share (excluding potentially dilutive shares) with non-GAAP earnings per share (including potentially dilutive shares).*

**Forward-Looking Statements**

This summary contains forward-looking statements which are made under the safe harbor provisions of the federal securities laws. These statements are based on the Company's management's current beliefs, expectations and assumptions about future events, conditions, and results and on information currently available to them. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. The Company believes that these risks and uncertainties include, but are not limited to, those described under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" set forth from time to time in the Company's filings and reports with the U.S. Securities and Exchange Commission ("SEC"), including its Annual Report on Form 10-K for the year ended December 31, 2025, and its Quarterly Reports on Form 10-Q, as well as future filings and reports by the Company, copies of which are available at <u>https://investors.telos.com</u> and on the SEC's website at <u>www.sec.gov</u>.

Although the Company bases these forward-looking statements on assumptions that its management believes are reasonable when made, the Company cautions the reader that forward-looking statements are not guarantees of future performance and that the Company's actual results of operations, financial condition and liquidity, and industry developments may differ materially from statements made in or suggested by the forward-looking statements contained in this summary. Given these risks, uncertainties, and other factors, many of which are beyond its control, the Company cautions the reader not to place undue reliance on these forward-looking statements. Any forward-looking statement speaks only as of the date of such statement and, except as required by law, the Company undertakes no obligation to update any forward-looking statement publicly, or to revise any forward-looking statement to reflect events or developments occurring after the date of the statement, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless specifically expressed as such, and should only be viewed as historical data.

------

**Non-GAAP Financial Measures**

In addition to our results determined in accordance with U.S. GAAP, we believe the non-GAAP financial measures of EBITDA, Adjusted EBITDA, EBITDA Margin, Adjusted EBITDA Margin, Incremental Adjusted EBITDA, Incremental Adjusted EBITDA Margin, Adjusted Net Income (Loss), Adjusted Earnings Per Share ("EPS"), Adjusted Gross Profit, Adjusted Gross Margin, Cash Gross Profit, Cash Gross Margin, Adjusted Operating Expenses, Cash Operating Expenses, Free Cash Flow and Free Cash Flow Margin are useful in evaluating our operating and cash flow performance. We believe that this non-GAAP financial information, when taken collectively with our GAAP results, may be helpful to readers of our financial statements because it provides consistency and comparability with past financial performance and assists in comparisons with other companies, some of which use similar non-GAAP financial information to supplement their GAAP results. The non-GAAP financial information is presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly-titled non-GAAP measures used by other companies. A reconciliation is provided below for each of these non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP.

Telos believes that EBITDA, EBITDA Margin, Adjusted EBITDA, Adjusted EBITDA Margin, Incremental Adjusted EBITDA, Incremental Adjusted EBITDA Margin, Adjusted Net Income (Loss), Adjusted EPS, Cash Operating Expenses, and Adjusted Operating Expenses provide the Board of Directors, management and investors with a clear representation of the Company's core operating performance and trends, provide greater visibility into the long-term financial performance of the Company, and eliminate the impact of items that do not relate to the ongoing operating performance of the business. Further, Adjusted EBITDA is used by the Board of Directors and management to prepare and approve the Company's annual budget, and to evaluate the performance of certain management personnel when determining incentive compensation. Adjusted Gross Profit, Cash Gross Profit, Adjusted Gross Margin and Cash Gross Margin provide management and investors a clear representation of the core economics of gross profit and gross margin without the impact of non-cash expenses and sunk costs expended. Telos uses Free Cash Flow and Free Cash Flow Margin to understand the cash flows that directly correspond with our operations and the investments the Company must make in those operations, using a methodology that combines operating cash flows and capital expenditures. Further, Free Cash Flow may be useful to management and investors in evaluating the Company's operating and cash flow performance and liquidity, and the Board of Directors uses this measure to evaluate the performance of certain management personnel when determining incentive compensation. Telos believes these non-GAAP financial measures facilitate the comparison of the Company's operating and cash performance on a consistent basis between periods by excluding certain items that may, or could, have a disproportionately positive or negative impact on the Company's results of operations in any particular period. When viewed in combination with the Company's results prepared in accordance with GAAP, these non-GAAP financial measures help provide a broader picture of factors and trends affecting the Company's results of operations.

EBITDA, Adjusted EBITDA, EBITDA Margin, Adjusted EBITDA Margin, Incremental Adjusted EBITDA, Incremental Adjusted EBITDA Margin, Adjusted Net Income (Loss), Adjusted EPS, Adjusted Gross Profit, Adjusted Gross Margin, Cash Gross Profit, Cash Gross Margin, Adjusted Operating Expenses, Cash Operating Expenses, Free Cash Flow and Free Cash Flow Margin are supplemental measures of operating and cash flow performance that are not made under GAAP and do not represent, and should not be considered as an alternative to gross profit, gross margin, net (loss) income, earnings per share, operating expenses or net cash flows (used in) provided by operating activities, as determined by GAAP.

The Company defines EBITDA as net (loss) income, adjusted for non-operating (income) expense, interest expense, provision for (benefit from) income taxes, and depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA, adjusted for stock-based compensation expense, impairment loss on goodwill and intangible assets, and restructuring expenses (adjustments). The Company defines EBITDA Margin, as EBITDA as a percentage of total revenue. The Company defines Adjusted EBITDA Margin as Adjusted EBITDA as a percentage of total revenue. The Company defines Incremental Adjusted EBITDA as the net change between current and prior year Adjusted EBITDA. The Company defines Incremental Adjusted EBITDA Margin as Incremental Adjusted EBITDA as a percentage of the net change between current and prior year total revenue. The Company defines Adjusted Net Income (Loss) as net (loss) income, adjusted for non-operating (income) expense, stock-based compensation expense, impairment loss on goodwill and intangible assets, and restructuring expenses (adjustments). The Company defines Adjusted EPS as Adjusted Net Income (Loss) divided by the weighted-average number of common shares outstanding for the period. The Company defines Adjusted Gross Profit as gross profit, plus stock-based compensation expense, impairment loss on intangible assets, and restructuring expenses charged under cost of sales. The Company defines Adjusted Gross Margin as a Adjusted Gross Profit as a percentage of total revenue. The Company defines Cash Gross Profit as Adjusted Gross Profit, plus depreciation and amortization. The Company defines Cash Gross Margin as Cash Gross Profit as a percentage of total revenue. The Company defines Adjusted Operating Expenses as operating expenses, adjusted for stock-based compensation expenses, impairment loss on goodwill and intangible assets, and restructuring expenses (adjustments). The Company defines Cash Operating Expenses as Adjusted Operating Expenses, adjusted for depreciation and amortization, and capitalized software development costs. Free Cash Flow is defined as net cash (used in) provided by operating activities, less net purchases of property and equipment, and capitalized software development costs. The Company defines Free Cash Flow Margin as Free Cash Flow as a percentage of total revenue.

------

EBITDA, Adjusted EBITDA, EBITDA Margin, Adjusted EBITDA Margin, Incremental Adjusted EBITDA, Incremental Adjusted EBITDA Margin, Adjusted Net Income (Loss), Adjusted EPS, Adjusted Gross Profit, Adjusted Gross Margin, Cash Gross Profit, Cash Gross Margin, Adjusted Operating Expenses, Cash Operating Expenses, Free Cash Flow, and Free Cash Flow Margin each has limitations as an analytical tool, and you should not consider any of them in isolation, or as a substitute for analysis of results as reported under GAAP. Among other limitations, each of EBITDA, Adjusted EBITDA, EBITDA Margin, Adjusted EBITDA Margin, Incremental Adjusted EBITDA, Incremental Adjusted EBITDA Margin, Adjusted Net Income (Loss), Adjusted EPS, Adjusted Gross Profit, Adjusted Gross Margin, Cash Gross Profit, Cash Gross Margin, Adjusted Operating Expenses, Cash Operating Expenses, Free Cash Flow and Free Cash Flow Margin does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments, does not reflect the impact of certain cash and non-cash charges resulting from matters considered not to be indicative of ongoing operations, and does not reflect income tax expense or benefit. Other companies in the Company's industry may calculate Adjusted EBITDA, Adjusted EBITDA Margin, Incremental Adjusted EBITDA, Incremental Adjusted EBITDA Margin, Adjusted Net Income (Loss), Adjusted EPS, Adjusted Gross Profit, Adjusted Gross Margin, Cash Gross Profit, Cash Gross Margin, Adjusted Operating Expenses, Cash Operating Expenses, Free Cash Flow and Free Cash Flow Margin differently than Telos does, which limits its usefulness as a comparative measure. Because of these limitations, neither EBITDA, Adjusted EBITDA, EBITDA Margin, Adjusted EBITDA Margin, Incremental Adjusted EBITDA, Incremental Adjusted EBITDA Margin, Adjusted Net Income (Loss), Adjusted EPS, Adjusted Gross Profit, Adjusted Gross Margin, Cash Gross Profit, Cash Gross Margin, Adjusted Operating Expenses, Cash Operating Expenses, Free Cash Flow, nor Free Cash Flow Margin should be considered as a replacement for gross profit, gross margin, net (loss) income, earnings per share, operating expenses, net cash flows (used in) provided by operating activities, or operating cash flow margin as determined by GAAP, or as a measure of profitability. Telos compensates for these limitations by relying primarily on the Company's GAAP results and using non-GAAP measures only for supplemental purposes.

**About Telos Corporation**

<u>Telos Corporation</u> (NASDAQ: TLS) empowers and protects the world's most security-conscious organizations with efficient, adaptable, and secure solutions that safeguard people, systems, and information. We deliver advanced capabilities across cyber governance, risk, and compliance (GRC) with Xacta<sup>®</sup>; identity and biometric solutions; secure networks and communications; and TSA PreCheck<sup>®</sup> enrollment services. Serving the U.S. federal government, regulated industries, and global enterprises, Telos helps customers stay ahead of evolving threats, accelerate compliance, and achieve mission success. Driven by purpose and guided by our core values, we build trusted partnerships, deliver superior solutions, and help create a more secure, interconnected world. Learn more at <u>www.telos.com</u>.

**Media:** 

<u>media@telos.com</u> 

**Investors:** 

<u>InvestorRelations@telos.com</u> 

------

**TELOS CORPORATION**

**CONSOLIDATED STATEMENTS OF OPERATIONS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | For the Three Months Ended | For the Three Months Ended | For the Year Ended | For the Year Ended |
| | December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 |
|  | *(in thousands, except per share amounts and share data)* | *(in thousands, except per share amounts and share data)* | *(in thousands, except per share amounts and share data)* | *(in thousands, except per share amounts and share data)* |
| &nbsp;&nbsp;&nbsp;Revenue – Security Solutions | $44830 | $21921 | $149600 | $76760 |
| &nbsp;&nbsp;&nbsp;Revenue – Secure Networks | 1947 | 4451 | 15205 | 31512 |
| Total revenue | 46777 | 26372 | 164805 | 108272 |
| &nbsp;&nbsp;&nbsp;Cost of sales – Security Solutions (excluding impairment loss, depreciation and amortization) | 26311 | 10847 | 83868 | 37352 |
| &nbsp;&nbsp;&nbsp;Cost of sales – Secure Networks (excluding impairment loss, depreciation and amortization) | 1503 | 3310 | 11740 | 24754 |
| &nbsp;&nbsp;&nbsp;Impairment loss on intangible assets |  |  |  | 5333 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 2606 | 1597 | 8180 | 6404 |
| Total cost of sales | 30420 | 15754 | 103788 | 73843 |
| Gross profit | 16357 | 10618 | 61017 | 34429 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Research and development expenses | 2075 | 1404 | 7057 | 8442 |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 17874 | 19141 | 78925 | 75487 |
| &nbsp;&nbsp;&nbsp;Goodwill impairment | 14916 |  | 14916 |  |
| &nbsp;&nbsp;&nbsp;Impairment loss on intangible assets |  |  |  | 6373 |
| Total operating expenses | 34865 | 20545 | 100898 | 90302 |
| Operating loss | (18508) | (9927) | (39881) | (55873) |
| &nbsp;&nbsp;&nbsp; Other income | 1600 | 724 | 3225 | 4023 |
| &nbsp;&nbsp;&nbsp; Interest expense | (129) | (152) | (553) | (644) |
| Loss before income taxes | (17037) | (9355) | (37209) | (52494) |
| Benefit from (provision for) income taxes | 726 | 25 | 663 | (26) |
| Net loss | $(16311) | $(9330) | $(36546) | $(52520) |
| Net loss per share: |  |  |  |  |
| Basic | $(0.22) | $(0.13) | $(0.50) | $(0.73) |
| Diluted | $(0.22) | $(0.13) | $(0.50) | $(0.73) |
| Weighted-average shares outstanding: |  |  |  |  |
| Basic | 73053 | 72435 | 72878 | 71850 |
| Diluted | 73053 | 72435 | 72878 | 71850 |

---

------

**TELOS CORPORATION**

**CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
| | As of December 31, | As of December 31, |
| | 2025 | 2024 |
|  | *(in thousands, except per share amount and share data)* | *(in thousands, except per share amount and share data)* |
| **Assets:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $53180 | $54578 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 17000 | 19172 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 10565 | 15092 |
| &nbsp;&nbsp;&nbsp;Deferred program expenses | 10006 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 3662 | 2576 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total current assets | 94413 | 91418 |
| Property and equipment, net | 3071 | 4283 |
| Finance lease right-of-use assets, net | 4170 | 5391 |
| Operating lease right-of-use assets | 410 | 622 |
| Goodwill | 3006 | 17922 |
| Intangible assets, net | 30281 | 30410 |
| Other assets | 4513 | 8189 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total assets | 139864 | 158235 |
| **Liabilities and Stockholders' Equity:** |  |  |
| Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $4087 | $1153 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 6900 | 4449 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation and benefits | 12309 | 7608 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities – current portion | 11223 | 6838 |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease obligations – current portion | 2033 | 1877 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations – current portion | 232 | 210 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total current liabilities | 36784 | 22135 |
| &nbsp;&nbsp;&nbsp;Contract liabilities – non-current portion | 1124 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease obligations – non-current portion | 5608 | 7641 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations – non-current portion | 186 | 418 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 53 | 813 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 159 | 91 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | 43914 | 31098 |
| Commitments and contingencies |  |  |
| Stockholders' equity: |  |  |
| Common stock, $0.001 par value, 250,000,000 shares authorized, 72,773,272 shares and 72,514,652 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 111 | 111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 459828 | 454502 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (96) | (129) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (363893) | (327347) |
| &nbsp;&nbsp;&nbsp;&nbsp; Total stockholders' equity | 95950 | 127137 |
| &nbsp;&nbsp;&nbsp;&nbsp; Total liabilities and stockholders' equity | $139864 | $158235 |

---

------

**TELOS CORPORATION**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | For the Three Months Ended | For the Three Months Ended | For the Year Ended | For the Year Ended |
| | December 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 |
|  | *(in thousands)* | *(in thousands)* | *(in thousands)* | *(in thousands)* |
| Cash flows from operating activities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(16311) | $(9330) | $(36546) | $(52520) |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to cash provided by (used in) operating activities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 5957 | 7394 | 30150 | 21411 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 3429 | 2499 | 11451 | 11867 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment | 14916 |  | 14916 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Recovery from) provision for doubtful accounts, net | (1) | 8 | 2 | (20) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Benefit from deferred income taxes | (801) | (37) | (760) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss (gain) on disposal of fixed assets | 14 | 4 | 15 | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized gain on fair value adjustment of investment | (750) |  | (750) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issuance costs | 18 | 18 | 70 | 70 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for inventory obsolescence | 418 | 108 | 418 | 108 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment loss on intangible assets |  |  |  | 11706 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in other operating assets and liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 3424 | (4299) | 2170 | 11272 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses, deferred program expenses, other current assets and other assets | (2254) | (1891) | (472) | (11926) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 3987 | (910) | 2724 | (7121) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation and benefits | (770) | (2129) | 650 | (7395) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities | (1384) | 58 | 5510 | 110 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities and other liabilities | (1912) | (2011) | 634 | (3491) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) operating activities | 7980 | (10518) | 30182 | (25938) |
| Cash flows from investing activities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Capitalized software development costs | (1680) | (2401) | (8176) | (11505) |
| &nbsp;&nbsp;&nbsp;Purchases of property and equipment, net | (30) | (1871) | (739) | (2252) |
| &nbsp;&nbsp;&nbsp;Purchase of investment |  |  |  | (3000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (1710) | (4272) | (8915) | (16757) |
| Cash flows from financing activities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Payments under finance lease obligations | (484) | (447) | (1877) | (1730) |
| &nbsp;&nbsp;&nbsp;Payment of tax withholding related to net share settlement of equity awards | (5654) |  | (7254) | (457) |
| &nbsp;&nbsp;&nbsp;Proceeds from exercise of stock options |  | 54 | 108 | 203 |
| &nbsp;&nbsp;&nbsp;Repurchase of common stock | (5988) |  | (13627) |  |
| &nbsp;&nbsp;&nbsp;Payments for debt issuance costs | (14) |  | (14) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (12140) | (393) | (22664) | (1984) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net change in cash, cash equivalents, and restricted cash | (5870) | (15183) | (1397) | (44679) |
| Cash, cash equivalents and restricted cash, beginning of period | 59190 | 69900 | 54717 | 99396 |
| Cash, cash equivalents and restricted cash, end of period | $53320 | $54717 | $53320 | $54717 |

---

------

**NON-GAAP FINANCIAL MEASURES** 

*(Unaudited)*

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** | **Reconciliation of Net Loss to EBITDA and Adjusted EBITDA; Net Loss Margin to EBITDA Margin and Adjusted EBITDA Margin; Incremental Net Loss and Net Loss Margin to Incremental Adjusted EBITDA and Incremental Adjusted EBITDA Margin** |
|  | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, |
|  | 2025 | 2025 | 2024 | 2024 | Year-over-Year Change | Year-over-Year Change | 2025 | 2025 | 2024 | 2024 | Year-over-Year Change | Year-over-Year Change |
|  | Amount | Margin | Amount | Margin | Amount | Margin | Amount | Margin | Amount | Margin | Amount | Margin |
|  | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* |
| Net loss | $(16311) | (34.9)% | $(9330) | (35.4)% | $(6981) | (34.2)% | $(36546) | (22.2)% | $(52520) | (48.5)% | $15974 | 28.3% |
| &nbsp;&nbsp;&nbsp;Other income | (1600) | (3.4)% | (724) | (2.8)% | (876) | (4.3)% | (3225) | (2.0)% | (4023) | (3.7)% | 798 | 1.4% |
| &nbsp;&nbsp;&nbsp;Interest expense | 129 | 0.3% | 152 | 0.6% | (23) | (0.1)% | 553 | 0.3% | 644 | 0.6% | (91) | (0.2)% |
| &nbsp;&nbsp;&nbsp;(Benefit from) provision for income taxes | (726) | (1.5)% | (25) | (0.1)% | (701) | (3.5)% | (663) | (0.3)% | 26 | —% | (689) | (1.2)% |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 3429 | 7.3% | 2499 | 9.5% | 930 | 4.5% | 11451 | 6.9% | 11867 | 11.0% | (416) | (0.7)% |
| EBITDA (Non-GAAP) | (15079) | (32.2)% | (7428) | (28.2)% | (7651) | (37.6)% | (28430) | (17.3)% | (44006) | (40.6)% | 15576 | 27.6% |
| &nbsp;&nbsp;Stock-based compensation expense <sup>(1)</sup> | 5957 | 12.7% | 7394 | 28.0% | (1437) | (7.0)% | 30150 | 18.3% | 21411 | 19.8% | 8739 | 15.4% |
| &nbsp;&nbsp;&nbsp;Goodwill impairment | 14916 | 31.9% |  | —% | 14916 | 73.1% | 14916 | 9.1% |  | —% | 14916 | 26.4% |
| &nbsp;&nbsp;&nbsp;Impairment loss on intangible assets |  | —% |  | —% |  | —% |  | —% | 11706 | 10.8% | (11706) | (20.7)% |
| &nbsp;&nbsp;Restructuring expenses <sup>(2)</sup> | 1501 | 3.2% | (167) | (0.6)% | 1668 | 8.2% | 1501 | 0.9% | 1270 | 1.1% | 231 | 0.4% |
| Adjusted EBITDA (Non-GAAP) | $7295 | 15.6% | $(201) | (0.8)% | $7496 | 36.7% | $18137 | 11.0% | $(9619) | (8.9)% | $27756 | 49.1% |

---

<sup>(1)</sup> The stock-based compensation expense to EBITDA is made up of stock-based compensation expense for the awarded RSUs, PSUs, and stock options, and other sources. Stock-based compensation expense for the awarded RSUs, PSUs and stock options was $4.3 million and $24.0 million million for the three and twelve months ended December 31, 2025, respectively, and $6.9 million and $19.4 million for the three and twelve months ended December 31, 2024, respectively. Stock-based compensation expense from other sources was $1.7 million and $6.1 million for the three and twelve months ended December 31, 2025, respectively, and $0.5 million and $2.1 million for the three and twelve months ended December 31, 2024, respectively. The other sources of stock-based compensation consist of accrued compensation, which the Company intends to settle in shares of the Company's common stock. However, the Company has the discretion to determine whether this compensation will ultimately be paid in stock or cash up until the date at which it is paid. Any change to the expected payment form would result in out-of-quarter adjustments to this add back to Adjusted EBITDA.

<sup>(2)</sup> The restructuring expenses include severance and other related benefit costs, and other non-cash restructuring costs related to implementing the restructuring plan.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Reconciliation of Net Loss to Adjusted Net Income (Loss), and EPS to Adjusted EPS** | **Reconciliation of Net Loss to Adjusted Net Income (Loss), and EPS to Adjusted EPS** | **Reconciliation of Net Loss to Adjusted Net Income (Loss), and EPS to Adjusted EPS** | **Reconciliation of Net Loss to Adjusted Net Income (Loss), and EPS to Adjusted EPS** | **Reconciliation of Net Loss to Adjusted Net Income (Loss), and EPS to Adjusted EPS** |
|  | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, |
|  | 2025 | 2024 | 2025 | 2024 |
|  | *(in thousands, except per share data)* | *(in thousands, except per share data)* | *(in thousands, except per share data)* | *(in thousands, except per share data)* |
| Net loss | $(16311) | $(9330) | $(36546) | $(52520) |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Other income | (1600) | (724) | (3225) | (4023) |
| &nbsp;&nbsp;Stock-based compensation expense <sup>(1)</sup> | 5957 | 7394 | 30150 | 21411 |
| &nbsp;&nbsp;&nbsp;Goodwill impairment | 14916 |  | 14916 |  |
| &nbsp;&nbsp;Impairment loss on intangible assets <sup>(3)</sup> |  |  |  | 11706 |
| &nbsp;&nbsp;Restructuring expenses <sup>(2)</sup> | 1501 | (167) | 1501 | 1270 |
| Adjusted net income (loss) (Non-GAAP) | $4463 | $(2827) | $6796 | $(22156) |
| Earnings (loss) per share, diluted | $(0.22) | $(0.13) | $(0.50) | $(0.73) |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Other income | (0.02) | (0.01) | (0.04) | (0.06) |
| &nbsp;&nbsp;Stock-based compensation expense <sup>(1)</sup> | 0.08 | 0.10 | 0.41 | 0.30 |
| &nbsp;&nbsp;&nbsp;Goodwill impairment | 0.20 |  | 0.21 |  |
| &nbsp;&nbsp;&nbsp;Impairment loss on intangible assets |  |  |  | 0.16 |
| &nbsp;&nbsp;Restructuring expenses <sup>(2)</sup> | 0.02 |  | 0.02 | 0.02 |
| &nbsp;&nbsp;Adjustment to diluted earnings per share <sup>(3)</sup> |  |  | (0.01) |  |
| Adjusted earnings (loss) per share, diluted (Non-GAAP) | $0.06 | $(0.04) | $0.09 | $(0.31) |
| Weighted-average shares to compute GAAP loss per share, diluted | 73053 | 72435 | 72878 | 71850 |
| Weighted-average shares to compute non-GAAP earnings (loss) per share, diluted <sup>(3)</sup> | 78189 | 72435 | 77131 | 71850 |

---

<sup>(1)</sup> The stock-based compensation expense to EBITDA is made up of stock-based compensation expense for the awarded RSUs, PSUs, and stock options, and other sources. Stock-based compensation expense for the awarded RSUs, PSUs and stock options was $4.3 million and $24.0 million million for the three and twelve months ended December 31, 2025, respectively, and $6.9 million and $19.4 million for the three and twelve months ended December 31, 2024, respectively. Stock-based compensation expense from other sources was $1.7 million and $6.1 million for the three and twelve months ended December 31, 2025, respectively, and $0.5 million and $2.1 million for the three and twelve months ended December 31, 2024, respectively. The other sources of stock-based compensation consist of accrued compensation, which the Company intends to settle in shares of the Company's common stock. However, the Company has the discretion to determine whether this compensation will ultimately be paid in stock or cash up until the date at which it is paid. Any change to the expected payment form would result in out-of-quarter adjustments to this add back to Adjusted Net Income (Loss).

<sup>(2)</sup> The restructuring expenses include severance and other related benefit costs (including outplacement services and continuing health insurance coverage), external consulting and advisory fees related to implementing the restructuring plan.

<sup>(3)</sup> For a period of net loss, potentially dilutive shares are not included in the calculation of diluted earnings (loss) per share, because to do so would be anti-dilutive. This is an adjustment used to reconcile GAAP earnings (loss) per share (excluding potentially dilutive shares) with non-GAAP earnings per share (including potentially dilutive shares).

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Reconciliation of Gross Profit to Adjusted Gross Profit and Cash Gross Profit; Gross Margin to Adjusted Gross Margin and Cash Gross Margin** | **Reconciliation of Gross Profit to Adjusted Gross Profit and Cash Gross Profit; Gross Margin to Adjusted Gross Margin and Cash Gross Margin** | **Reconciliation of Gross Profit to Adjusted Gross Profit and Cash Gross Profit; Gross Margin to Adjusted Gross Margin and Cash Gross Margin** | **Reconciliation of Gross Profit to Adjusted Gross Profit and Cash Gross Profit; Gross Margin to Adjusted Gross Margin and Cash Gross Margin** | **Reconciliation of Gross Profit to Adjusted Gross Profit and Cash Gross Profit; Gross Margin to Adjusted Gross Margin and Cash Gross Margin** | **Reconciliation of Gross Profit to Adjusted Gross Profit and Cash Gross Profit; Gross Margin to Adjusted Gross Margin and Cash Gross Margin** | **Reconciliation of Gross Profit to Adjusted Gross Profit and Cash Gross Profit; Gross Margin to Adjusted Gross Margin and Cash Gross Margin** | **Reconciliation of Gross Profit to Adjusted Gross Profit and Cash Gross Profit; Gross Margin to Adjusted Gross Margin and Cash Gross Margin** | **Reconciliation of Gross Profit to Adjusted Gross Profit and Cash Gross Profit; Gross Margin to Adjusted Gross Margin and Cash Gross Margin** |
|  | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, |
|  | 2025 | 2025 | 2024 | 2024 | 2025 | 2025 | 2024 | 2024 |
|  | Amount | Margin | Amount | Margin | Amount | Margin | Amount | Margin |
|  | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* | *(dollars in thousands)* |
| Gross profit | $16357 | 35.0% | $10618 | 40.3% | $61017 | 37.0% | $34429 | 31.8% |
| Adjustments: |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Stock-based compensation expense — cost of sales | 159 | 0.3% | 228 | 0.8% | 652 | 0.4% | 828 | 0.8% |
| &nbsp;&nbsp;&nbsp;Impairment loss on intangible assets – cost of sales |  | —% |  | —% |  | —% | 5333 | 4.9% |
| &nbsp;&nbsp;&nbsp;Restructuring expenses — cost of sales | 494 | 1.1% | (52) | (0.2)% | 494 | 0.3% | 341 | 0.3% |
| Adjusted gross profit (Non-GAAP) | 17010 | 36.4% | 10794 | 40.9% | 62163 | 37.7% | 40931 | 37.8% |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization — cost of sales | 2606 | 5.5% | 1597 | 6.1% | 8180 | 5.0% | 6404 | 5.9% |
| Cash gross profit (Non-GAAP) | $19616 | 41.9% | $12391 | 47.0% | $70343 | 42.7% | $47335 | 43.7% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Reconciliation of Net Cash Provided by (Used in) Operating Activities to Free Cash Flow and Free Cash Flow Margin** | **Reconciliation of Net Cash Provided by (Used in) Operating Activities to Free Cash Flow and Free Cash Flow Margin** | **Reconciliation of Net Cash Provided by (Used in) Operating Activities to Free Cash Flow and Free Cash Flow Margin** | **Reconciliation of Net Cash Provided by (Used in) Operating Activities to Free Cash Flow and Free Cash Flow Margin** | **Reconciliation of Net Cash Provided by (Used in) Operating Activities to Free Cash Flow and Free Cash Flow Margin** |
|  | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, |
|  | 2025 | 2024 | 2025 | 2024 |
|  | *(in thousands)* | *(in thousands)* | *(in thousands)* | *(in thousands)* |
| Net cash flows provided by (used in) operating activities | $7980 | $(10518) | $30182 | $(25938) |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Capitalized software development costs | (1680) | (2401) | (8176) | (11505) |
| &nbsp;&nbsp;&nbsp;Purchases of property and equipment, net | (30) | (1871) | (739) | (2252) |
| Free cash flow (Non-GAAP) | $6270 | $(14790) | $21267 | $(39695) |
| Revenue | $46777 | $26372 | $164805 | $108272 |
| Operating cash flow margin | 17.1% | (39.9)% | 18.3% | (24.0)% |
| Free cash flow margin (Non-GAAP) | 13.4% | (56.1)% | 12.9% | (36.7)% |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Reconciliation of Operating Expenses to Adjusted Operating Expenses and Cash Operating Expenses** | **Reconciliation of Operating Expenses to Adjusted Operating Expenses and Cash Operating Expenses** | **Reconciliation of Operating Expenses to Adjusted Operating Expenses and Cash Operating Expenses** | **Reconciliation of Operating Expenses to Adjusted Operating Expenses and Cash Operating Expenses** | **Reconciliation of Operating Expenses to Adjusted Operating Expenses and Cash Operating Expenses** |
|  | For the Three Months Ended December 31, | For the Three Months Ended December 31, | For the Year Ended December 31, | For the Year Ended December 31, |
|  | 2025 | 2024 | 2025 | 2024 |
|  | *(in thousands)* | *(in thousands)* | *(in thousands)* | *(in thousands)* |
| Operating expenses | $34865 | $20545 | $100898 | $90302 |
| Adjustments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Stock-based compensation expense | (5798) | (7166) | (29498) | (20583) |
| &nbsp;&nbsp;&nbsp;Goodwill impairment | (14916) |  | (14916) |  |
| &nbsp;&nbsp;&nbsp;Impairment loss on intangible assets |  |  |  | (6373) |
| &nbsp;&nbsp;&nbsp;Restructuring expenses | (1007) | 115 | (1007) | (929) |
| Adjusted operating expenses (Non-GAAP) | 13144 | 13494 | 55477 | 62417 |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | (823) | (902) | (3271) | (5463) |
| &nbsp;&nbsp;&nbsp;Capitalized software development costs | 1579 | 2403 | 8055 | 11262 |
| Cash operating expenses (Non-GAAP) | $13900 | $14995 | $60261 | $68216 |

---

<br>